The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients
Abstract The prognosis of diffuse large B‐cell lymphoma (DLBCL) patients depends on lymphoma‐ and patient‐related risk factors and is best estimated by the international prognostic index (IPI). The aim of the study was to determine whether the average relative dose intensity (ARDI) of an anthracycli...
Saved in:
Main Authors: | Monika Długosz‐Danecka, Sebastian Szmit, Tomasz Ogórka, Aleksander B. Skotnicki, Wojciech Jurczak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatment
by: Juliana V. Costa, et al.
Published: (2025-01-01) -
Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOP
by: Min Kyeong Kim, et al.
Published: (2016-12-01) -
Baseline [18F]FDG PET/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP
by: Zeying Wen, et al.
Published: (2025-01-01) -
Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
by: Tomohiro Kadota, et al.
Published: (2019-03-01) -
Clinical Characteristics and Treatment Response of a Novel ELANE Gene Mutation (c.295_303del) in Congenital Neutropenia
by: Junjie Ning
Published: (2024-02-01)